Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.
| Image |  |
|---|---|
| Description | scientific article published on 25 August 2010 |
| Author/s |
author: Philippe Colombat Jean-Pierre Vilque Virginie Lucas Bernard Desablens Remy Gressin Noel Jean Milpied Vincent Delwail Steven Le Gouill Antoine Thyss |
| Publication date | August 25, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |